Company information & drug savings for Deciphera Pharmaceuticals medications

Deciphera Pharmaceuticals is a biopharmaceutical company developing kinase inhibitor cancer therapies. Based in Waltham, Massachusetts, the company created QINLOCK (ripretinib), a switch-control kinase inhibitor for advanced gastrointestinal stromal tumor (GIST) after prior treatment with other kinase inhibitors. Deciphera’s precision oncology research targets resistance mechanisms in cancer.